로딩 중…
지수 로딩 중…
Mirum Pharmaceuticals, Inc.
MIRM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$107.13+4.99%
2026-06-18
Price Chart
Mirum Pharmaceuticals, Inc.+110.89%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $6.53B |
| Revenue | $570M |
| Net Income | $-799M |
| Total Assets | $891M |
| Net Assets | $242M |
| Value | |
| P/B | 26.94x |
| P/S | 11.47x |
| FCF Yield | -2.64% |
| Profitability | |
| ROA | -89.67% |
| Op. Margin | -12.31% |
| Revenue Growth | 43.28% |
| Financial Health | |
| Debt Ratio | 267.40% |
| Total Debt | $324M |
| FCF | $-173M |
| Cash | $325M |
| Current Ratio | 2.09x |
| Performance | |
| 1Y Return | 110.89% |
| 1M Return | 12.00% |
| From 52W High | -6.84% |
| 1Y MDD | -20.55% |
| Trading | |
| Volume | 1,459,514 shares |
| Trading Value | $155M |
| Per Share | |
| EPS | $-0.47 |
| BPS | $6.27 |